Morgan Stanley Finance LLC has filed a pricing supplement for its Variable Income Memory Auto-Callable Notes, which are set to mature on October 30, 2031. This filing is significant as it represents the company's ongoing efforts to expand its structured investment offerings, particularly in a competitive market.
Background
Morgan Stanley Finance LLC, classified under the Standard Industrial Classification (SIC) 6211, operates in the Security Brokers, Dealers & Flotation Companies sector. The company is a subsidiary of Morgan Stanley, a well-known financial services firm. The recent filing, dated October 29, 2026, is part of a series of filings that include multiple pricing supplements, all aimed at enhancing the company’s investment product suite.
What the Filing Says
The filing includes details about the Variable Income Memory Auto-Callable Notes, which are based on the performance of the worst-performing stocks among Dell Technologies Inc., Palantir Technologies Inc., CrowdStrike Holdings, Inc., and Marvell Technology, Inc. The notes will pay a variable coupon and are fully guaranteed by Morgan Stanley, indicating a strong backing for potential investors.
Impact
This development may significantly affect investors looking for structured investment products that offer potential returns linked to high-profile technology stocks. The notes are designed for those who are concerned about principal risk while seeking opportunities for above-market interest rates. However, the structure of these notes implies that poor performance from any of the underlying stocks could adversely affect returns.
What's Next
The filing does not specify what happens next, but it is likely that Morgan Stanley Finance LLC will continue to market these notes to investors as part of its broader investment strategy.
Read Next
Workers United Files to Sell $8.4 Million in Amalgamated Stock
Carvana Co. files to sell 10 million shares of stock
Platford Giles Richard to Sell 55,617 Takeda Shares
Takeda's Teresa Bitetti to Sell 46,609 Shares Amid Tax Obligations
Kiniksa Pharmaceuticals reports significant stock sale by officer
Moat Ross to Sell Over 103,000 Shares of Kiniksa Pharmaceuticals










